SCHEMBL6859979

SCHEMBL6859979

CCCC(=O)O[C@@]1(C(=O)COC(=O)Cc2ccccc2)CC[C@H]2[C@@H]3CC(F)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 5/20 0.55
▸ LMNA P02545 4/20 0.55
▸ NPSR1 Q6W5P4 1/20 0.55
▸ NR3C1 P04150 6/20 0.52
▸ PGR P06401 7/20 0.52
▸ CYP3A4 P08684 6/20 0.52
▸ USP2 O75604 1/20 0.52
▸ CYP2D6 P10635 1/20 0.52
▸ CYP2C9 P11712 1/20 0.52
▸ ABCB11 O95342 3/20 0.51
▸ AR P10275 3/20 0.48
▸ F2 P00734 1/20 0.48
▸ NR3C2 P08235 2/20 0.47
▸ ADRA1A P35348 2/20 0.46
▸ ADORA3 P0DMS8 1/20 0.46
▸ CHRM1 P11229 1/20 0.46
▸ SLC6A2 P23975 1/20 0.46
▸ SLC6A3 Q01959 1/20 0.46
▸ KCNH2 Q12809 1/20 0.46
▸ HSD17B10 Q99714 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6859977 1.00 HIF1A (0.55) HIF1ALMNANPSR1NR3C1PGR
SCHEMBL7599781 0.92 NR3C1 (0.62) HIF1ALMNANPSR1NR3C1PGR
SCHEMBL21132007 0.90 HIF1A (0.68) HIF1ALMNANPSR1NR3C1PGR
SCHEMBL6859064 0.87 NR3C1 (0.69) HIF1ALMNANR3C1PGRCYP3A4
SCHEMBL6859066 0.87 NR3C1 (0.69) HIF1ALMNANR3C1PGRCYP3A4
SCHEMBL6857023 0.87 NR3C1 (0.61) HIF1ALMNANR3C1PGRCYP3A4
SCHEMBL6857015 0.87 NR3C1 (0.61) HIF1ALMNANR3C1PGRCYP3A4
SCHEMBL11431166 0.87 PGR (0.66) HIF1ALMNANPSR1NR3C1PGR
SCHEMBL11438672 0.87 PGR (0.58) HIF1ALMNANPSR1NR3C1PGR
SCHEMBL11807623 0.86 PGR (0.60) HIF1ALMNANPSR1NR3C1PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6835724-B2 Topical antiinflammatory agents for treating inflammatory dermatoses AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-12-28 — — US disclosed
US-20020103392-A1 CORTICOID-17,21-DICARBOXYLIC ESTERS AND CORTICOSTEROID 17-CARBOXYLIC ESTER 21-CARBONIC ESTERS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICALS CONTAINING THESE COMPOUNDS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2002-08-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020103392-A1 CORTICOID-17,21-DICARBOXYLIC ESTERS AND CORTICOSTEROID 17-CARBOXYLIC ESTER 21-CARBONIC ESTERS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICALS CONTAINING THESE COMPOUNDS NR3C1, HSD3B1, HSD17B7 HIF1A 2813/4885LMNA 3177/4885NPSR1 3858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback